BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19917249)

  • 21. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
    Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
    Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
    Whitlock NC; Trostel SY; Wilkinson S; Terrigino NT; Hennigan ST; Lake R; Carrabba NV; Atway R; Walton ED; Gryder BE; Capaldo BJ; Ye H; Sowalsky AG
    Oncogene; 2020 Aug; 39(34):5663-5674. PubMed ID: 32681068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.
    He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY
    Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.
    Rao S; Lyons LS; Fahrenholtz CD; Wu F; Farooq A; Balkan W; Burnstein KL
    Oncogene; 2012 Feb; 31(6):716-27. PubMed ID: 21765461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis.
    Stelloo S; Nevedomskaya E; Kim Y; Hoekman L; Bleijerveld OB; Mirza T; Wessels LFA; van Weerden WM; Altelaar AFM; Bergman AM; Zwart W
    Oncogene; 2018 Jan; 37(3):313-322. PubMed ID: 28925401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
    Grad JM; Dai JL; Wu S; Burnstein KL
    Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
    Pomerantz MM; Li F; Takeda DY; Lenci R; Chonkar A; Chabot M; Cejas P; Vazquez F; Cook J; Shivdasani RA; Bowden M; Lis R; Hahn WC; Kantoff PW; Brown M; Loda M; Long HW; Freedman ML
    Nat Genet; 2015 Nov; 47(11):1346-51. PubMed ID: 26457646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
    Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
    Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
    Chen Z; Wu D; Thomas-Ahner JM; Lu C; Zhao P; Zhang Q; Geraghty C; Yan PS; Hankey W; Sunkel B; Cheng X; Antonarakis ES; Wang QE; Liu Z; Huang TH; Jin VX; Clinton SK; Luo J; Huang J; Wang Q
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6810-6815. PubMed ID: 29844167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination.
    Xu K; Shimelis H; Linn DE; Jiang R; Yang X; Sun F; Guo Z; Chen H; Li W; Chen H; Kong X; Melamed J; Fang S; Xiao Z; Veenstra TD; Qiu Y
    Cancer Cell; 2009 Apr; 15(4):270-82. PubMed ID: 19345326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP.
    Koochekpour S; Lee TJ; Wang R; Sun Y; Delorme N; Hiraiwa M; Grabowski GA; Culig Z; Minokadeh A
    J Cell Biochem; 2007 Jun; 101(3):631-41. PubMed ID: 17171640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
    Kim IJ; Kang TW; Jeong T; Kim YR; Jung C
    Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-alpha reductase inhibitor influences expression of androgen receptor and HOXB13 in human hyperplastic prostate tissue.
    Jung C; Park Y; Kim YR; Ryu SB; Kang TW
    Int Braz J Urol; 2013; 39(6):875-83. PubMed ID: 24456780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
    Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
    Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
    Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
    Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiandrogens prevent stable DNA-binding of the androgen receptor.
    Farla P; Hersmus R; Trapman J; Houtsmuller AB
    J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.